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How can the EQA provider encourage the participation in Pre-Analytical schemes
Providing a quality sample and ensuring the best laboratory practices should be the aim of Pre-Analytical Phase. 
With analytical phase strictly controlled, pre-analytical phase should be the laboratories target for improvement processes. Concerning to this, it is important to have in place a proper system for error 
detection for this extra-analytical phase and to be able to detect errors that have a significant negative effect on sample quality and patient health. Although laboratory managers are becoming to 
concern about these issues, the participation rate on the national program on pre-analytical phase is still very low, which means that the EQA provider should have an intervention more active than it 
has with the analytical phase.
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Introduction
Material and Methods
Results
PNAEQ has a total of 196 laboratories participants in EQA schemes for clinical area in 2017. Of this, only 10% were registered on pre-analytical scheme. Three of them are from developing
Portuguese spelling countries. In 2015 PNAEQ has created a Working Group on pre-analytical phase. Since then, all participants are invited to participate on this annual meeting.
The two schemes involving PNAEQ are mystery client and presential audit:
Mystery client: two anonymous telephone calls were made to the laboratories registered in this scheme on 2 different days, one in the morning period and one in the afternoon period. The calls were
made based on an interview guide simulating a patient with questions. The simulated required analyses were for Haematology, Clinical Chemistry and Microbiology areas.
Presential audit: In the annual WG meeting was proposed that two PNAEQ elements would perform an audit in two randomly selected laboratories (Lab A and Lab B) among those registered in this
scheme. The two auditors observed 5 blood drawings by 3 different technicians, in a total of 15 observations. The items observed focused on three main themes: sample identification, sample
quality and safety practices, spread over 10 items. This audit form was previously provided to all registered participants as a tool to be used by laboratories. In addition, it was possible to compare
and validate the results obtained by auto evaluation of laboratory (its own auditor) and PNAEQ auditor.
A report concerning these two schemes was sent to each laboratory and it was asked what were the actions implemented to improve good practices in 2017.
The participation rate and performance results for each of the schemes were as follows:
Mystery client: In 2017 were received 19/20 results, corresponding on 95% participation rate. Note that participation rate in other
type of schemes which depend only of participants are around 62% in audits and 64% for monitoring indicators. The results
show that there was no coherence in the information provided by the collaborators in 40% of the questions raised (Table 1).
Presential audit: For the laboratory A, the PNAEQ audit evidenced non-compliance with good practices in 3 items, when
comparing with the laboratory auto evaluation: 3-blood draw system used (67% of the blood drawings observed by PNAEQ were
made with open system, i.e., needle and syringe, in contrast to 0% reported by laboratory), 5-order of draw (7% of the blood
drawings observed by PNAEQ used the incorrect order of draw, according to the CLSI document H3-A6, as opposed to 0%
reported by laboratory) and 9-identification of samples in the presence of the patient (in 53% of the blood drawings observed by
PNAEQ, the collectors tubes were not identified during the blood drawing, contrasting with the 0% reported by laboratory)
(Graphics 1, 2 and 3).
For the laboratory B, the PNAEQ audit confirmed the good practices comparing with the laboratory auto evaluation.
 These tools were created to facilitate the detection, monitoring, evaluation and correction or elimination of pre-analytical errors when regularly used by laboratories. This is possible while
participants can use these real situations to compare their practices with other laboratories and within the laboratory comparing collaborators practices. The approach of these types of surveys is
especially educational.
 These two type of schemes will be repeated in the 4th trimester of 2017 so we can verify if laboratories have implemented preventive/corrective actions to improve good practices in pre-analytical
routine.
 The cooperation between PNAEQ and participants will be maintained in future rounds of Pre-Analytical Phase. This cooperation allows to clarify laboratories difficulties in data collection and to
share national and international guidelines and recommendations, which should improve samples quality and ensure the best laboratory practices.
 In the Working Group annual meetings on Pre-Analytical Phase, there will be discussed the selected indicators and the tools most adapted to the participants collection data, based on national
and international results.
 In addition, PNAEQ will continuing to promote training actions for implementing the best laboratory practices in Pre-Analytical Phase.
 PNAEQ will continue to work with other European EQA providers, especially in the distribution of online surveys to Portuguese laboratories.
Aim and Objective
In order to contradict this weak participation and to reach the laboratories needs, PNAEQ (Programa Nacional de Avaliação Externa da Qualidade) has launched two types of schemes in which
laboratories participation depends mainly of the EQA provider. One is the “mystery client”, which simulates a real life scenario to verify if the information provided to the patient depends on the
laboratory collaborator. The other one is a presential audit, which identify some of the real errors occurred during the blood drawing. The aim of these two types of surveys is to demonstrate that
most of the pre-analytical errors are detectable and, more important than that, they can be corrected or eliminated when pre-analytical phase is controlled.
Questions 2017 (%)
Patient preliminary preparation 5
Instructions provided by laboratory 47
Information available on laboratory website 63
Total amount to pay 63
Laboratory schedule 47
Possibility of appointment the blood drawing 16
Average 40
Table 1: Percentage of different answers in the two telephone calls (call 1 versus
call 2), made in the morning period or in the afternoon period, for each question.
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Graphic 1: Percentage of blood drawings observed relative to question 3-Blood
draw system used?, reported by laboratory and by PNAEQ, for laboratory A.
(Legend: NA – No Answer)
Graphic 2: Percentage of blood drawings observed relative to question 5-Order of
draw?, reported by laboratory and by PNAEQ, for laboratory A.
(Legend: NA – No Answer)
Graphic 3: Percentage of blood drawings observed relative to question 9-
Collector tubes identified in patient's presence?, reported by laboratory and by
PNAEQ, for laboratory A. (Legend: NA – No Answer)
